Standout Papers

<sup>68</sup>Ga-FAPI PET/CT: Tr... 2005 2026 2012 2019 920
  1. 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer (2019)
    Clemens Kratochwil, Paul Flechsig et al. Journal of Nuclear Medicine
  2. 68Ga-Complex Lipophilicity and the Targeting Property of a Urea-Based PSMA Inhibitor for PET Imaging (2012)
    Matthias Eder, Martin Schäfer et al. Bioconjugate Chemistry
  3. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein (2018)
    Thomas Lindner, Anastasia Loktev et al. Journal of Nuclear Medicine
  4. The hematopoietic factor G-CSF is a neuronal ligand that counteracts programmed cell death and drives neurogenesis (2005)
    Armin Schneider, Carola Krüger et al. Journal of Clinical Investigation
  5. A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts (2018)
    Anastasia Loktev, Thomas Lindner et al. Journal of Nuclear Medicine
  6. 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers (2018)
    Frederik L. Giesel, Clemens Kratochwil et al. Journal of Nuclear Medicine
  7. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer (2015)
    Martina Benešová, Martin Schäfer et al. Journal of Nuclear Medicine
  8. PSMA-Targeted Radionuclide Therapy of Metastatic Castration-Resistant Prostate Cancer with 177Lu-Labeled PSMA-617 (2016)
    Clemens Kratochwil, Frederik L. Giesel et al. Journal of Nuclear Medicine
  9. F-18 labelled PSMA-1007: biodistribution, radiation dosimetry and histopathological validation of tumor lesions in prostate cancer patients (2016)
    Frederik L. Giesel, Boris Hadaschik et al. European Journal of Nuclear Medicine and Molecular Imaging
  10. Diagnostic performance of 68Ga-PSMA-11 (HBED-CC) PET/CT in patients with recurrent prostate cancer: evaluation in 1007 patients (2017)
    Ali Afshar‐Oromieh, Tim Holland‐Letz et al. European Journal of Nuclear Medicine and Molecular Imaging
  11. Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention (2019)
    Anastasia Loktev, Thomas Lindner et al. Journal of Nuclear Medicine
  12. The Theranostic PSMA Ligand PSMA-617 in the Diagnosis of Prostate Cancer by PET/CT: Biodistribution in Humans, Radiation Dosimetry, and First Evaluation of Tumor Lesions (2015)
    Ali Afshar‐Oromieh, Clemens Kratochwil et al. Journal of Nuclear Medicine

Immediate Impact

12 by Nobel laureates 9 from Science/Nature 69 standout
Sub-graph 1 of 20

Citing Papers

Covalent targeted radioligands potentiate radionuclide therapy
2024 StandoutNature
Advances in PET imaging of cancer
2023 Standout
29 intermediate papers

Works of Walter Mier being referenced

A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts
2018 Standout
Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein
2018 Standout
and 19 more

Author Peers

Author Last Decade Papers Cites
Walter Mier 6470 3666 5618 4566 229 14.6k
Hans‐Jürgen Wester 10481 3619 5201 6565 304 18.4k
Victor A. Levin 2341 5016 3718 4934 277 16.0k
Joel S. Greenberger 3495 7680 3045 3094 444 18.3k
William H. McBride 3357 5623 6513 2740 301 16.7k
Roger Schibli 9021 3207 4698 3331 369 14.5k
Matthias Eder 5724 2974 3263 5934 191 12.9k
Nai‐Kong V. Cheung 2275 6648 5436 1671 389 16.3k
Edouard C. Nice 2358 9297 4528 1475 304 16.7k
Warren D.W. Heston 3542 3818 2514 5204 150 10.6k
Dennis E. Hallahan 2684 6491 3126 1922 265 13.0k

All Works

Loading papers...

Rankless by CCL
2026